“May all be happy, may all be healed, may all be at peace and may no one ever suffer."
Myelodysplastic syndrome (MDS), also known as myelodysplastic disease, is a group of blood disorders characterized by abnormal production and maturation of blood cells in the bone marrow. In MDS, the bone marrow produces abnormal, immature blood cells that do not function properly, leading to low blood cell counts and an increased risk of infections, bleeding, and other complications.
The exact cause of MDS is often unknown, but it is thought to be related to genetic mutations or damage to the DNA within blood cells. MDS is more common in older adults and is often associated with exposure to certain chemicals or radiation.
Symptoms of MDS may include fatigue, weakness, shortness of breath, easy bruising or bleeding, frequent infections, and an enlarged spleen. In some cases, MDS may progress to acute myeloid leukemia (AML).
Treatment for MDS depends on the severity of the disease and the individual's overall health. Mild cases may not require treatment, but regular monitoring of blood counts and bone marrow function is important. For more severe cases, treatment options may include medications to stimulate blood cell production, blood transfusions, or bone marrow or stem cell transplant.
Prognosis for MDS varies widely depending on the type and severity of the disease, as well as the individual's age and overall health. In some cases, MDS may progress rapidly, while in others it may remain stable for many years. Regular medical care and monitoring are important for individuals with MDS to help manage symptoms, monitor disease progression, and address any complications.